2009
DOI: 10.1590/s0100-72032009000800003
|View full text |Cite
|
Sign up to set email alerts
|

Efeitos da hiperprolactinemia sobre o útero de camundongos no proestro

Abstract: Data have shown that hyperprolactinemia induced by metoclopramide determines endometrial proliferation and interferes with the ovarian function, mainly in the progesterone production.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2011
2011
2013
2013

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 19 publications
0
3
0
1
Order By: Relevance
“…We also observed a significant decrease in progesterone levels coexisted with PRL serum elevation. Overall, these disturbances may have deleterious effects on ovarian function,7 endometrial tissue,9 and embryo implantation 8. Finally, hyperprolactinemia caused by metoclopramide in mice is due to an increase in the number and activity of lactotrophs and these alterations seem to be independent of the cycle phase.…”
Section: Discussionmentioning
confidence: 99%
“…We also observed a significant decrease in progesterone levels coexisted with PRL serum elevation. Overall, these disturbances may have deleterious effects on ovarian function,7 endometrial tissue,9 and embryo implantation 8. Finally, hyperprolactinemia caused by metoclopramide in mice is due to an increase in the number and activity of lactotrophs and these alterations seem to be independent of the cycle phase.…”
Section: Discussionmentioning
confidence: 99%
“…On the last day, one hour after drug administration, the mice were sacrificed, except for those not in proestrus. These continued to receive the drugs until they entered that phase 1 .…”
Section: Methodsmentioning
confidence: 99%
“…De fato nosso trabalho identificou grande expressão dessas isoformas nesse tecido, o que complementaria a explicação das modificações morfológicas encontrada nos trabalhos anteriores Panzam et al, 2006;Gomes et al, 2009 O PRLR uterino tem sido alvo de estudo nas duas últimas décadas, mas pouco se sabe sobre sua biologia em animais submetidos à hiperprolactinemia (Harbaum et al, 2010). Nosso estudo aponta que o tratamento com metoclopramida pode alterar a expressão dos receptores PRLR-S3 e PRLR-L no útero.…”
Section: Prl -úTerounclassified
See 1 more Smart Citation